CLINICAL EFFICACY OF VARIOUS MEDICAMENTS USED FOR PULPOTOMY IN PRIMARY MOLARS – A COMPARATIVE STUDY

Authors

  • Prachi Goyal Department of Pedodontics and Preventive Dentistry, M M Institute of Dental Sciences, Mullana, Haryana
  • I K Pandit Department of Pedodontics and Preventive Dentistry, DAV Dental College, Yamunanagar, Haryana
  • Neeraj Gugnani Department of Pedodontics and Preventive Dentistry, DAV Dental College, Yamunanagar, Haryana
  • Monika Gupta Department of Pedodontics and Preventive Dentistry, DAV Dental College, Yamunanagar, Haryana
  • Neha Singla Department of Pedodontics and Preventive Dentistry, Swami Devi Dyal Hospital and Dental College, Barwala, Haryana
  • Vikas Singla Department of Oral Medicine & Radiology, Yamuna Institute of Dental Sciences & Research, Yamunanagar, Haryana

Keywords:

Primary molars, Pulpotomy, Ferric sulphate, glutaraldehyde, Mineral trioxide aggregate, clinical, radiographical

Abstract

Background and objectives: Retention of pulpally involved primary teeth in a healthy state until the time of exfoliation remains to be one of the challenges for pedodontist. The aim of this study was to evaluate and compare the efficacy of Ferric sulphate, glutaraldehyde and Mineral trioxide aggregate as pulpotomy medicaments in primary molars.

Method: A total of forty–five primary molars from thirty two children aged 4-8 years were selected for pulpotomy procedure. Teeth were randomly divided into three equal groups of fifteen teeth in each group. Patients in different groups were intended to be treated with different pulpotomy agents. All the molars were evaluated clinically and radio graphically at regular intervals of 24 hrs, 1, 3 and 6 months.

Results: The observations were statistically analyzed using Chi-square test. MTA exhibited overall best results as pulpotomy agent for primary molars followed by 15.5% Ferric sulphate, whereas 2% buffered glutaraldehyde showed least favourable results both clinically and radio graphically.

Conclusion: All the materials showed varying degrees of success clinically and radio graphically, however further larger sample size and longer observational period should be carried out to reach sound conclusions.

Downloads

Download data is not yet available.

References

Ruth Holt, Graham Roberts and Crispian Scully. Oral health and disease BMJ 2000 June 17; 320(7250): 1652–1655.

Psoter WJ, Reid BC, Katz RV. Malnutrition and dental caries: a review of the literature. Caries Res 2005; 39(6):441-7.

Cordeiro MM, Rocha MJ. The effects of peri radicular inflamation and infection on a primary tooth and permanent successor. J Clin Pediatr Dent 2005; 29(3):193-200.

Autio-Gold JT, Tomar SL. Prevalence of non cavitated and cavitated carious lesions in 5-year-old head start school children in Alachua County, Florida. Pediatr Dent 2005; 27(1):54-60.

Alireza Sarraf Shirazi, Minoo Rezaifar, Maryam Talebi, Ali Mortazavi and Katyoon Safari Malekabadi Application of bonding system as a sub-base material following electrosurgical pulpotomy treatment in primary teeth: a novel technique Iranian Journal of Medical Hypotheses and Ideas Irn J Med Hypotheses Ideas, 2009, 3:12

Miguel-Angel Simancas-Pallares, Antonio-José Díaz-Caballero, Luz-Mayda Luna-Ricardo Mineral trioxide aggregate in primary teeth pulpotomy. A systematic literature review Med Oral Patol Oral Cir Bucal. 2010 Nov 1; 15 (6):e942-6.

McDonald RA, Avery DR, Dean JR. Treatment of Deep Caries, Vital Pulp Exposure, and Pulpless Teeth. Dentistry for the Child and Adolescent. 8th ed. Missouri: Mosby; 2004, pp. 389-412.

Agamy, H.A., N.S.Bakry, M.F. Mounir Maha and D.R.Avery. Comparison of mineral trioxide aggregate and formocresol as pulp capping agents in pulpotomized primary teeth. Pediatr. Dent. 2004:26(4): 302-309. PMID:15344622

Anna B. Fuks, CD Pulp therapy for the primary and young permanent dentitions. Dental Clinics of North America Vol.44, No.3, July 2000.

Ranly DM. Pulpotomy therapy in primary teeth: new modalities for old rationales. Pediatr Dec 1994 Nov-Dec; 16(6):403-9

Eidelman, E. G.Holan and A.B.Fuks. Mineral trioxide aggregate vs formocresol in pulpotomized primary molars: A preliminary report. Pediatr. Dent. 2001 23(1):15-18PMID:11242724.

Agamy H.A, N.S. Bakry, M.F. Mounir Maha and D.R.Avery. Comparison of mineral trioxide aggregate and formocresol as pulp capping agents in pulpotomized primary teeth. Pediatr. Dent., 2004; 26(4):302-309.PMID:15344622

International Agency for Research on Cancer, WHO, Press release no.153, june 15, 2004.

Prakash C, Chandra S, Jaiswal JN. Formocresol and glutaraldehyde pulpotomies in primary teeth. J Pedod. 1989 Summer; 13(4): 314-22

Ranly DM, Horn D, Hubbard GB. Assessment of the systemic distribution and toxicity of glutaraldehyde as a pulpotomy agent. Pediatr Dent. 1989 Mar; 11(1):8-13.

Lemon Rr, Steele Pj, Jeansonne Bg. Ferric sulphate hemostasis effect on osseous wound healing. Left in situ for maximum exposure J Endod1993 Apr; 19(4):170-3.

American Academy of Pediatric Dentistry. Guideline on pulp therapy for primary and young permanent teeth. Pediatr Dent. 2004; 26:115-9.

Naik S, Hegde Amitha M Mineral trioxide aggregate as a pulpotomy agent in primary molars: An in vivo study. JISPPD 2005; 23 (1):13-16.

Holan G, Eidelman E, Fuks AB. Long-term evaluation of pulpotomy in primary molars using mineral trioxide aggregate or formocresol. Pediatr Dent. 2005; 27 : 129-36.

Farsi N, Alamoudi N, Balto K, Mushayt A. Success of mineral trioxide aggregate in pulpotomized primary molars. J Clin Pediatr Dent 2005; 29:307–11.

Huth K.C., Paschos E., Hajek-Al-Khatar N., Hollweck R., Crispin A., Hickel R. Effectiveness of 4 Pulpotomy Techniques Randomized Controlled Trial. J DENT RES 2005; 84; 1144

Huth K.C., Paschos E., Hajek-Al-Khatar N., Hollweck R., Crispin A., Hickel R. Effectiveness of 4 Pulpotomy Techniques Randomized Controlled Trial. J DENT RES 2005; 84; 1144

Ranly D.M, Franklin Garcia Godoy and Diane Horn, "Time, Concentration, and PH Parameters for the Use of Glutaraldehyde as a Pulpotomy Agent: An In Vitro Study 1987; 9: 199,

Smith, N L; Seale, N S; Nunn, M E. Ferric sulfate pulpotomy in primary molars: a retrospective study. Pediatr Dent, 2000; 22(3): 192-9.

Torabinejad M, Pitt Ford TR, McKendry DJ, Abedi HR, Miller DA, Kariyawasam SP. Histologic assessment of mineral trioxide aggregate as a root-end filling in monkeys. J Endod. 1997;23:225-8.

Magnusson B. Therapeutic pulpotomy in primary molars –clinical and histological follow up. I. Calcium hydroxide paste as a wound dressing. Odontologisk Revy 1970; 21: 415–431.

Fuks AB, Holan G, Davis JM, Eidelman E. Ferric sulfate versus dilute formocresol in pulpotomized primary molars: Long term follow up. Pediatr Dent 1997; 19:327-30.

Ranly D.M, Franklin Garcia Godoy and Diane Horn, "Time, Concentration, and PH Parameters for the Use of Glutaraldehyde as a Pulpotomy Agent: An In Vitro Study 1987; 9: 199,

R Caicedo, PV Abbott, DJ Alongi, MY Alarcon. Clinical, radiographic and histological analysis of the effects of mineral trioxide aggregate used in direct pulp capping and pulpotomies of primary teeth. Australian Dental Journal 2006;51:(4):297-305

Tzong-Ping Tsai; Huey-LI S; Liang-Hui Tseng. Glutaraldehyde preparations and pulpotomy in primary molars.Oral surgery, Oral medicine, oral pathologyISSN 0030-4220 1993, 76 (3): 346-350.

Maroto M, Barberia E, Planells P, Garcia-Godoy F. Dentin bridge formation after mineral trioxide aggregate (MTA) pulpotomies in primary teeth. Am J Dent 2005; 18: 151–154.

Fei AL, Udin RD, Johnson R. A clinical study of ferric sulphate as a pulpotomy agent in primary teeth. Pediatr Dent 1991 Nov- Dec; 13(6):327 -32.

Maroto M, Barberia E, Vera V, Garcia-Godoy F. Mineral trioxide aggregate as pulp dressing agent in pulpotomy treatment of primary molars: 42-month clinical study. Am J Dent 2007; 20: 283–286.

Published

2016-05-15

How to Cite

Goyal, P. ., Pandit, I. K. ., Gugnani, N. ., Gupta, M. ., Singla, N. ., & Singla, V. . (2016). CLINICAL EFFICACY OF VARIOUS MEDICAMENTS USED FOR PULPOTOMY IN PRIMARY MOLARS – A COMPARATIVE STUDY. International Journal of Research and Development in Pharmacy & Life Sciences, 5(3), 2107-2116. Retrieved from https://ijrdpl.com/index.php/ijrdpl/article/view/226